Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Cash & Equivalents (2016 - 2025)

Utah Medical Products has reported Cash & Equivalents over the past 16 years, most recently at $85.8 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $85.8 million for Q4 2025, up 3.35% from a year ago — trailing twelve months through Dec 2025 was $85.8 million (up 3.35% YoY), and the annual figure for FY2025 was $85.8 million, up 3.35%.
  • Cash & Equivalents for Q4 2025 was $85.8 million at Utah Medical Products, up from $84.3 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for UTMD hit a ceiling of $93.8 million in Q1 2024 and a floor of $56.0 million in Q1 2021.
  • Median Cash & Equivalents over the past 5 years was $82.6 million (2024), compared with a mean of $77.7 million.
  • Biggest five-year swings in Cash & Equivalents: soared 41.45% in 2021 and later decreased 11.17% in 2025.
  • Utah Medical Products' Cash & Equivalents stood at $61.0 million in 2021, then increased by 23.09% to $75.1 million in 2022, then increased by 23.74% to $92.9 million in 2023, then dropped by 10.65% to $83.0 million in 2024, then rose by 3.35% to $85.8 million in 2025.
  • The last three reported values for Cash & Equivalents were $85.8 million (Q4 2025), $84.3 million (Q3 2025), and $82.2 million (Q2 2025) per Business Quant data.